Healthcare - Biotechnology - NASDAQ - US
$ 54.72
-8.28 %
$ 5.07 B
Market Cap
-14.55
P/E
INCOME STATEMENT
4.01 M
REVENUE
-223 M
OPERATING INCOME
-215 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Crinetics Pharmaceuticals, Inc.
| Revenue | 4.01 M |
| Cost Of Revenue | 0 |
| Gross Profit | 4.01 M |
| Operating Expenses | 227 M |
| Operating Income | -223 M |
| Other Expenses | -8.08 M |
| Net Income | -215 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Revenue | 4.0 | 4.7 | 1.1 | 71 K | 1.2 | 2.4 | 2.0 | 0.6 |
| GROSS PROFIT | ||||||||
| Cost Of Revenue | 0 | 1.4 | 1.3 | 57.0 | 1.1 | 24.5 | 9.2 | 5.1 |
| Gross Profit | 4.0 | 3.3 | (0.2) | (56.9) | 80 K | (22.1) | (7.2) | (4.5) |
| OPERATING INCOME | ||||||||
| Operating Expenses | 226.6 | 172.6 | 108.8 | 75.0 | 53.8 | 28.7 | 9.1 | 6.0 |
| Selling, General and Administrative Expenses | 58.1 | 42.4 | 24.5 | 18.0 | 13.5 | 6.7 | 1.9 | 1.5 |
| Research and Development Expenses | 168.5 | 130.2 | 84.3 | 57.0 | 41.5 | 24.5 | 9.2 | 5.1 |
| Operating Income | (222.6) | (167.9) | (107.7) | (75.0) | (53.8) | (28.7) | (9.1) | (6.0) |
| PRE-TAX INCOME | ||||||||
| Interest Income Expense | 0 | 4.3 | 0 | 0 | 0 | 0 | 8 K | 11 K |
| Total Other Income | 8.1 | 4.0 | 61 K | 1.1 | 3.4 | 1.6 | 30 K | 25 K |
| Pre-Tax Income | (214.5) | (163.9) | (107.6) | (73.8) | (50.4) | (27.1) | (9.2) | (6.0) |
| NET INCOME | ||||||||
| Tax Provision | 0 | (4.0) | (0.9) | (0.9) | (0.9) | 1.6 | 40 K | 10 K |
| Net Income | (214.5) | (160.0) | (106.7) | (72.9) | (49.5) | (27.1) | (9.2) | (6.0) |
| EPS | 3.69 | 3.08 | 2.78 | 2.39 | 2.05 | 2.23 | 0.66 | 0.43 |